Live
CAC 40 · Healthcare ·

EssilorLuxottica (EL) formalises agreement to move eyewear production to Italy

EssilorLuxottica shares advanced on 9 June 2026 following the announcement of a strategic agreement to relocate a portion of its connected eyewear production to Italy. The optical giant's stock is trading at €178.70, a gain of 3.2% during the session.

The company formalised an agreement with Italian trade unions today to repatriate some smart eyewear manufacturing. This initiative is viewed as a strategically significant move for EssilorLuxottica's high-tech wearables segment.

This progression reverses a slight correction from the previous session, when the shares closed at €173.15. The French group had previously garnered market interest last week, with its stock boosted by the 2025 dividend and analyst praise.

What Does It Mean

Why EssilorLuxottica's Production Relocation is Driving its Shares

EssilorLuxottica is the global powerhouse behind much of the eyewear we see and wear. They design, manufacture, and distribute a vast range of optical products, from Essilor corrective lenses to iconic Ray-Ban and Oakley frames. Essentially, they equip billions of people worldwide with both essential vision correction and fashionable accessories, capturing a significant share of the global optics market by integrating their entire value chain, from research to retail.

The primary catalyst for today's share price movement is a strategic decision to bring a portion of its smart eyewear production back to Italy. This move, formalised with Italian trade unions, is seen as a clever play for EssilorLuxica's high-tech wearables division, promising enhanced quality control, improved traceability, and a stronger brand identity for these advanced products. While favourable analyst reports and the 2025 dividend had already generated some market interest last week, this specific production shift is the key driver today.

Investors have clearly welcomed this initiative, pushing EssilorLuxottica's shares up by 3.2% today, trading at €178.70. This marks a notable rise from its previous close of €173.15.

Think of a luxury car manufacturer that decides to produce a critical, high-tech component in-house, rather than outsourcing it to a distant supplier. By doing so, they gain direct oversight of the manufacturing process, ensuring the component meets their exacting standards for performance and reliability, and reinforcing the perception of superior craftsmanship and brand authenticity for their vehicles.

Tags

EssilorLuxottica

EL·Euronext Paris·CAC 40·🇫🇷
Industry
Medical - Instruments & Supplies
CEO
Francesco Milleri
Employees
153,498
Headquarters
Paris, FR
Listed
2000
About

EssilorLuxottica S.A. (EL) is a global leader in ophthalmic products, specialising in the design, manufacture, and distribution of lenses, frames, and sunglasses. Its operations span North America, Europe, Latin America, Asia, Oceania, and Africa, organised across five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The company's diverse portfolio includes well-known lens brands such as Varilux, Crizal, and Transitions, alongside optical instruments for professionals. Its Equipment division supplies digital surfacing and lens coating machines. The Sunglasses and Readers segment offers a wide array of non-prescription eyewear under various brands, including Foster Grant and Bolon. With a network of 490 prescription laboratories and edging-mounting facilities, EssilorLuxottica was founded in 1849 and is headquartered in Paris, France.